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487J. Milic et al. / Science of the Total Environment 688 (2019) 486–4931. IntroductionThe Stockholm Convention on Persistent Organic Pollutants (POPs)
aims to restrict and ultimately eliminate production, use, release and
storage of POPs, and currently, the Convention lists 29 chemicalsmeeting
the criteria for classiﬁcation as POPs,which are: adverse effects to human
health, persistence, bio-accumulation and potential for long-range envi-
ronmental transport (StockholmConvention, 2004). Consequently, POPs
could have signiﬁcant economic consequences, which will affect eco-
nomic growth as well as welfare (Stockholm Convention, 2004).
The Republic of Serbia ratiﬁed the Stockholm Convention in 2009
and prepared a National Implementation Plan (NIP, 2010) and an Up-
dated plan (UNIP, 2015). For the purpose of this study, we will give a
brief description concerning the cost of POP-polluted environments
and POP-related disease costs in Serbia, i.e. a socio-economic impact
over a timeline of ﬁve years.
1.1. POPs in Serbia
According to UNIP, it is established there is no speciﬁc, deliberate
production, import or export of POPs in Serbia, nor any use of EU-
banned POP compounds in agriculture or industry (UNIP, 2015). How-
ever, the country held 1.35 tons of POP pesticides, identiﬁed in 2014
(Stevanovic-Carapina et al., 2016). Concerning POP industrial chemicals,
the amounts were assessed for the following types: polychlorinated
biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs),
hexabromocyclododecane (HBCDD) and perﬂuorooctanesulfonic acid
(PFOS). Based on the results of a detailed inventory of PCB-containing
transformers in Serbia, as well as on additional testing performed, it
was estimated that approximately 7% (around 4480) of transformers
contain PCBs, as does 585 tons of oil from transformers (UNIDO,
2014). Furthermore, 5–8% of low voltage transformers (LVTs) in Serbia
are contaminated with PCBs (i.e. around 4200 LVTs), because PCBs
have remained as residues after cleaning and recharging transformers
with mineral oil. The amount of contaminated oil from LVTs is assessed
at 1200–1900 tons. Concerning waste, the quantity of generated PCB
waste amounts to 112.2 tons, and the amount of PCB waste exported
was 419 tons in total. The estimated amount of PBDEs in vehicles in
Serbia was around 13 tons, while cathode ray tube casings in electrical
and electronic equipment hold amounts ranging from 46.9 to 136.9
tons. The assessed overall quantity of HBCDD on the market in Serbia
was 37.3 tons, although we emphasize this assessment is unreliable
due to the unavailability of some relevant data. Concerning PFOS
chemicals, the presence ofﬁreﬁghting foams containing PFOSwas iden-
tiﬁed in the past, but most of that foam was utilized during the NATO
bombing campaign in 1999. Data on the import of Teﬂon and Teﬂon-
based products that could contain PFOS suggest a need for increased in-
spection, supervision and laboratory analysis of the PFOS content in
these products (Stevanovic-Carapina et al., 2016).
Based on the results of a preliminary inventory of unintentionally pro-
duced POPs, these chemicals are emitted to the environment from differ-
ent sources located throughout Serbia. Themost signiﬁcant unintentional
POP sources are: open burning processes; PCBs released from electrical
equipment, and; production of electric and heating energy. Furthermore,
in Serbia, there are over 3000 unsanitary landﬁlls scattered around the
country, and the signiﬁcant portion of POP emissions reaching the envi-
ronment from these existing dumpsites indicates inappropriate applica-
tion of waste management systems (Stevanovic-Carapina et al., 2016).
1.2. Contents and importance of the socio-economic impact assessment
The socio-economic impact assessment (SEIA) of hazardous
chemicals is deﬁned as a systematic assessment of a potential impact
of economic and other activities to all parts of society, including local
communities and groups, the civil society, the private and public sec-
tors, etc. (Eythorsson et al., 2015). The SEIA is a tool for analyzing andmanaging intended and unintended inﬂuences or effects (both positive
and negative), interventions (policies, programs, plans and projects)
and any other social change initiated by these interventions (Brnjas
et al., 2015; Fischer et al., 2005).
The above-mentioned impacts of hazardous chemicals can be classi-
ﬁed into three basic groups, as follows: impact on the health of people;
impact on the environment, and; impact on economic development
(Eythorsson et al., 2015). All these aspects have been the focus of spe-
ciﬁc research efforts, but the strongest emphasis is put on assessing
the impact on human health, and particularly the impact in the work
place. As well, numerous research activities have focused on the effects
that chemicals have on the environment, while a somewhat lower num-
ber of research activities have dealt with their economic development
impact (Eythorsson et al., 2015).
One of the most important efforts to quantify the adverse effects of
chemicals on human health has been made by the World Health Orga-
nization (WHO) (Prüss-Ustün et al., 2011; WHO, 1994, 2010). The ad-
verse impact of chemicals on human health was quantiﬁed with the
help of two basic indicators: the number of deaths (per annum) and
the number of Disability-Adjusted Life Years (DALY), i.e., the number
of days lost to deteriorating health and illnesses. According to estimates
presented in theWHO study (Prüss-Ustün et al., 2011) presented in the
current study, in 2004, around 4.9 million deaths (8.3% of the total
deaths) and 86 million DALY (5.7% of the total DALY) globally were
the consequence of effects of the analyzed chemicals on the environ-
ment and humans. Additionally, the effects of chemicals in the work
place, acute chemical poisoning and poisoning with pesticides have
caused 375,000, 240,000 and 186,000 deaths, respectively. The magni-
tude and importance of these effects can be presented evenmore clearly
by comparing them with other known causes of deaths which are re-
corded with relatively more reliable data. Therefore, in the observed
year, 2.16 million people died of HIV/AIDS, 1.5 million of tuberculosis,
1.27 million from trafﬁc accidents, 0.9 million of malaria, etc.
(McKenna et al., 2005).
There have also been numerous attempts to monetize the adverse
effects of hazardous chemicals, i.e., to present them in ﬁnancial terms.
These attempts are characterized by different approaches which reﬂect
the different methodologies applied, different scope of research and
choice of chemicals (individual or groups) which have been researched,
and so their results are very difﬁcult to compare.
Research activities of this type put special emphasis on determining
the effects of chemicals in thework place. Thus, Pickvance et al. showed
that if the application of measures speciﬁed by the framework of the EU
REACH programme (Registration, Evaluation, Authorisation and Re-
striction of Chemicals – an EU regulation introduced in 2007) ceased
to exist, in the period of the next 30 years, an additional € 90.9 billion
would be generated as costs (Pickvance et al., 2005). These include
costs of medical treatments, effects of reduced productivity, and re-
duced quality of life due to chronic illnesses such as pulmonary diseases
and dermatitis (Pickvance et al., 2005). On the other hand, increased
costs to chemical and other afﬁliated industries resulting from the appli-
cation of REACHmeasures have been estimated at € 2.8–5.2 billion, for a
period of 15 years.
The objective of the current study was to quantify the impact of POP
chemicals on human health in Serbia, speciﬁcally on the carcinogenic
and non-carcinogenic diseases and, where it was possible, to monetize
these effects and express them in ﬁnancial terms. This study also
assessed the health and environmental cost beneﬁts in the scenario of
a 5-year phase out (disposal, decontamination and reduction) of POPs
in the environment. To the best of our knowledge, this the ﬁrst time
such analysis has been conducted.
2. Materials and methods
Bearing in mind there are no speciﬁc data or research based on
which registered cases of illness can be classiﬁed by cause, it is very
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POPs. In the present work, we give preliminary estimations of costs of
medical treatments of diseases which can potentially be caused by
POPs, under a three pillar approach:
- To analyze the health impact of POPs in Serbia. Given the limited re-
sources (ﬁnancial, human and time) available for research on this
subject, the health impact assessment in Serbia in this study is some-
what limited to an attempt to estimate the cost of medical treat-
ments of diseases which could potentially be caused by POPs.
Special emphasis was put on the following diseases coded under
the International Classiﬁcation of Illnesses (WHO, 2016): Code can-
cer: C15 Malignant oesophageal tumor; Neoplasm malignum
oesophagi; C16 Malignant stomach tumor; Neoplasm malignum
gasteris; C17 Malignant small intestine tumor; Neoplasmmalignum
intestini tenuis; C18 Malignant appendiceal tumor; Neoplasm
malignum caeci; C19 Malignant rectosigmoid colon junction
tumor; Neoplasm malignum juncturae coli rectosigmoidis; C20
Malignant rectal tumor; Neoplasm malignum recti; C21 Malignant
anal tumor, not speciﬁed; Neoplasm malignum ani, non
speciﬁcatum; C22 Malignant liver and bile duct tumor; Neoplasma
malignum hepatis et ductuum biliarium intrahepaticorum; C23
Malignant gallbladder tumor; Neoplasma malignum vesicae felleae;
C24 External bile duct tumor; Neoplasma malignum ductus biliaris
extrahepatici; C25 Malignant pancreas tumor; Neoplasma
malignum pancreatis; C26 Malignant gastrointestinal tumor, not
speciﬁed; Neoplasma malignum tractus intestinalis, non
speciﬁcatum; C34 Malignant tracheal tumor; Neoplasma malignum
bronchi principalis; C43 Lip melanoma; Melanoma malignum labii
oris; C44 Other malignant skin tumors; Neoplasma malignum cutis
alius; C46 Kaposi's sarcoma – malignant connective tissue tumor;
Sarcoma Kaposi; C50 Malignant nipple and areola tumor;
Neoplasma malignum papillae et areolae; C73 Malignant thyroid
tumor; Neoplasmamalignum glandulae thyreoideae; C81Hodgkin's
disease –Malignant lymphatic tissue tumor; Morbus Hodgkin; C82
Follicular Non-Hodgkin lymphoma of small cells with incised nuclei;
Lymphoma non-Hodgkin folliculare cellularum parvarum cum nu-
cleis incisis; C83 diffuse non-Hodgkin lymphomaof small cells; Lym-
phoma non-Hodgkin cellularum parvarum diffusum; C84 Mycosis
fungoides; Mycosis fungoides (cancer codes), and K71 Liver disease
caused by toxins; Morbus hepatis toxicus; K72 Liver insufﬁciency;
Insufﬁcientia hepatis; K73 Chronic liver inﬂammation; Hepatitis
chronica; E03.2 Thyroid deﬁciency caused by the use of drugs
and other substances; Hypothyroidisms medicamentosus et hy-
pothyroidisms propter usum substantiarum exogenium aliarum;
E03 Other types of thyroid deﬁciency; Hypothyroidisms alius;
G11 Ataxia – hereditary movement disorder; Ataxia hereditaria;
G40 Epilepsy; Epilepsia; G43 Migraine – one-sided headache at-
tacks; Migraena; G44 Other headaches; Cephalalgiae aliae; G45
Temporary ischemia – insufﬁcient blood ﬂow to the brain and re-
lated syndromes; Ischaemia cerebri transitiva et syndromae af-
ﬁnes; G46 Cerebrovascular disease; Sindromae vasculares
cerebrales (I60-I67+); G47 Sleep disorder; Disordines somni;
D80-D82 Immunodeﬁciency; N0-N19 Renal Insufﬁciency; P05-
P08 Diseases related to pregnancy duration and fetus growth
(other effects codes).
- To analyze the environmental impact of POPs in Serbia, data from
ofﬁcial government sources and scientiﬁc research was used, and
to predict costs of disposal and decontamination of POPs for a 5-
year phase-out scenario, methodology from UNIP was used
(UNIP, 2015). In brief, 1. Screening of localities of high risk; 2. Pre-
liminary investigation for localities where data missing are iden-
tiﬁed; 3. Human health and environmental risk assessment
procedure for sites where contamination is identiﬁed; 4. For con-
taminated sited use of BAT/BEP for protection of further exposure
of humans and environment (i.e. bioremediation) and; 5.Simultaneously with bioremediation provide monitoring in
order to check proposed measures efﬁcacy (UNIP, 2015).
- To assess the socio-economic impact of POPs in Serbia, we used
two indicators: (1) medical costs calculated as a percentage of
the country's GDP, and; (2) beneﬁt:cost ratio (BCR) for a 5-year
phase-out scenario. The percentage of medical costs as a share
of the GDP represents the gross potential contribution of environ-
mental POPs to loss of GDP due to health care costs. The BCR is the
ratio of beneﬁts versus costs which indicates the level of beneﬁt
that will be accrued for every €1 of cost (Shively, 2012). The
BCR should be greater than 1.0 in order for the proposed mea-
sures to be economically acceptable and it is unacceptable envi-
ronmentally that we do not clean up the POPs.
3. Results and discussion
3.1. Health impact of POPs in Serbia
POPs cause a variety of adverse health effects, including repro-
ductive, developmental, endocrine, and carcinogenic effects
(Carpenter, 2011; Mouly and Toms, 2016; Vested et al., 2014). The
primary route of exposure for the human population is through
contaminated food, but other routes include contaminated water,
air, proximity to POP-contaminated sites, and dermal contact with
everyday use products that contain POPs (mainly PFOS and PBDEs).
Furthermore, it is proven that POPs can be transferred through the
human placenta and breast milk to newborns (Fång et al., 2015;
Mead, 2008).
The Serbian NIP for the Stockholm Convention states the daily aver-
age PCB intake of an adult weighing 70 kg equals 0.79 μg (this is 1.1% of
the acceptable daily intake), based on the concentrations of POP com-
pounds in food, atmosphere and soil in Novi Sad city (NIP, 2010).
Petrovic et al. (2008) assessed dioxin and PCB intake via food in the
Serbian population and calculated an average intake of these chemicals
as 3.14 pg TEQ/kg/day. Thiswasmore than themaximum intake recom-
mended for the EU by the Scientiﬁc Council on Food, set at 2 pg TEQ/kg/
day, still lower than themaximum intake recommended by theWHOof
4 pg TEQ/kg/day, but much higher than new setted tolerable weekly in-
take for dioxins and dioxin-like PCBs in food of 2 pg TEQ/kg,which is ap-
proximately 0.3 TEQ/kg/day. The new TWI is seven-times lower than
the previous EU tolerable intake set by the European Commission's for-
mer Scientiﬁc Committee on Food in 2001 and the new TWI is protec-
tive against effects on semen quality (EFSA, 2018). However, the goal
of the WHO is to achieve an intake of 1 pg TEQ/kg/day, so in Serbia,
the level of dioxins and PCBs ingested via food, even though a determin-
istic procedure was applied, indicates the need to raise awareness of
these food contaminants (Petrovic et al., 2008; NIP, 2010). Škrbić
(2008)measured the concentrations of sixmarker PCBs in 35 composite
samples of crop products and by-products of the food processing indus-
try and assessed the dietary intake of these chemicals by the adult
Serbian population. The average daily intake of the marker PCBs was
assessed to be 172.2 ng/day using ameanweight of 60 kg for the general
population in Serbia. Wheat-based products contributed largely
(141.0 ng/day) to the estimated value, due to fact that these products
are notably consumed in Serbia, while the contributions of edible oil
(19.8 ng/day) and sugar (11.4 ng/day) were not pronounced. Other im-
portant sources included meat products, ﬁsh, dairy products and eggs
(Škrbić, 2008). Another study revealed the results of monitoring three
groups of POPs – DDT, HCH and PCBs – in early human breast milk for
27 years (1982–2009), indicating that concentrations of DDT and HCH
had decreasing trends from 1982 to 2009, with small rises in 1994
(Vukavić et al., 2013). Concentrations of PCBs in early human breast
milk generally decreased from 1982 to 2009; decreases were smooth
and steep until 1994, but two small peaks occurred in 2003 and 2009.
Although the estimated daily intake of PCBs was far below the upper
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milk in 2003 and 2009 was a clear indication of environmental inﬂux
of these compounds after 1994 (Vukavić et al., 2013). A report on dioxin
congener patterns for two samples of free-range chicken eggs from the
municipality of Obrenovac, Serbia showed the speciﬁc prevalence of
PCDD (polychlorinated dibenzodioxin) congeners over other congeners
in the eggs (5.2 and 2.2 pg TEQ/g of PCDD/dibenzofurans in fat). These
results point to chemical contamination from the nearby thermal
power plant being a potential source of the egg contamination
Obrenovac being a potential source of the egg contamination (Petrlík,
2015).
Currently, Serbia does not have any ofﬁcial data or speciﬁc research
based onwhich registered cases of human disease could be classiﬁed by
cause. Therefore, it is very difﬁcult to estimate the critical effects which
could be attributed to human exposure to POPs. For the purpose of ini-
tial estimation, we have identiﬁed the potential effects of 24 POPs on
people's health (Table 1) and highlighted those effects with the most
detrimental consequences (ATSDR, 2018; RHIF, 2017). Beginning with
identiﬁed or potential cancers and other diseases caused by POPs, we
put special emphasis on diseases coded by the International Classiﬁca-
tion of Illnesses into two groups: cancer coded and other effects
coded. A review of diseases and their corresponding codes is presented
in Table 1.
Based upon ofﬁcial data from the Republic Health Insurance Fund
(RHIF), the costs of medical treatment in Serbia for two groups of pa-
tients with diseases are shown. The G1 group (Table 2) consists of car-
cinogenic diseases and G2 group (Table 3) comprises non-
carcinogenic diseases, but in both cases, the diseases could potentially
be the consequence of exposure to POPs (RHIF, 2017). This analysis
covers a 5-year period, as a set period for further socio-economic
analysis.
The annual costs related to the treatment of G1 group diseases in
Serbia in the observed period ranged between approximately € 156mil-
lion to € 176 million. The average costs of treating individual patients
were relatively stable and oscillated up to € 1500 (Table 2).
The annual costs for treatment of G2 groupdiseases in the 5-year pe-
riod were between approximately € 237 million and € 260 million. The
average cost of treating individual patients with G2 group diseases was
between € 835 and € 1010 per patient (Table 3).
As is the case with many environmental pollutants, it is extremely
difﬁcult to establish that illnesses or diseases are directly attributable
to exposure to a speciﬁc POP or group of POPs. This difﬁculty is further
underscored by the facts that (a) POPs rarely occur in the environment
as a single compound, and (b) individual ﬁeld studies are insufﬁcient to
provide compelling evidence of cause and effect in their own right. Be-
cause of that, these estimations should primarily be regarded as an illus-
tration, and the uncertainties must be taken into account, like genetics,
life style as well as demographic characteristics of Republic of Serbia.
Namely, import and export trends were checked based on Serbian
data, however before 2006, Serbia was part of three different Unions,
with Motenegro, as United Republic of Yugoslavia and Socialistic Feder-
ative Republic of Yugoslavia, and this entire factor can inﬂuence results.
The main purpose here is to provide a basic idea of the level of these
costs rather than to precisely determine the costs of medical treatment
of the illnesses.
WHO indicates that around 20% of carcinogenic diseases are caused
by hazardous chemicals (WHO, 2002). If we begin with a hypothesis
that adverse effects of POP compounds might comprise at least 10% of
the adverse effects of hazardous chemicals (or that they cause approxi-
mately 2% of all cases of carcinogenic diseases), we could reach a rather
approximate estimate of costs required for treatment of the aforemen-
tioned diseases caused by POPs in Serbia. The fact that the WHO re-
search pertains to the causes of carcinogenic diseases which originate
from the work place means that the results are likely underestimated,
even though it might be expected that work place exposure is more in-
tense than general environmental exposure (WHO, 2002).According to this assumption, the costs of medical treatment of car-
cinogenic diseases which could be connected to POPs ranged from € 3.1
to 3.5 million annually (Table 4).
As regards the non carcinogenic diseases, it is not possible to present
any kind of quantitative estimate due to lack of data and research. Nev-
ertheless, primarily for the sake of illustration and presenting a very
general picture about possible monetized human health effects of
POPs, if we begin from the same assumption that POP compounds con-
tribute 2% of the total effects of hazardous chemicals in humans, we
would get annual estimates of these costs ranging from € 4.7 to 5.2 mil-
lion (Table 4).
Themedical treatment costs of G1 and G2 diseases that could be po-
tentially caused by POPs are, in total, between € 7.3 and 8.4 million an-
nually (€ 40,131,300 for the 5-year period).
In Serbia, the RHIF covers approximately 70% of the population. Be-
sides that, some drugs and medical treatments require co-payments
even if the patient is covered by the RHIF. Therefore, realistic health ex-
penditure covered by the RHIF is assessed as being only 59% of the total
expenditure (Burki, 2018). Bearing this in mind, the total cost to Serbia
of medical treatment for diseases which could be potentially caused by
POPs could be around € 68,019,000 for the 5-year period.
3.2. Environmental impact of POPs in Serbia
The examination of the quality of surface waters and groundwa-
ter in accordance with the Programme of Systematic Water Quality
Control is carried out by the Serbian Environmental Protection
Agency. Information received on the status of the waters is the
basis for making decisions regarding water management. Continu-
ous monitoring of water quality serves as a relevant source of profes-
sional information on the state of water resources as well as a basis
for protection of waters from contamination and for determining
optimal use of waters.
Regarding the POP content in river waters in Serbia in 2012, lindane
was registered in 9 out of 54 sites. Concentrations of aldrin, chlordane
(α and γ), endrin, hexachlorobenzene (HCB) and PCBs were below
the limit of quantiﬁcation (LОQ). All maximum concentrations mea-
sured were below the deﬁned maximum permissible concentrations
(MPC) (SEPA, 2017a, 2017b).
Regarding POPs in river sediment in 2012, PCBs were registered in 8
of 47 sites in concentrations lower than targeted values (TV) as deﬁned
in the relevant Serbian regulation (SOG, 2012). The maximum concen-
tration of HCB measured was close to the limit of quantiﬁcation
(LOQ), whereas the concentrations of all other substances were below
their respective LOQs (Beškoski et al., 2013).
Besides monitoring POPs in surface waters in Serbia, in accordance
with the monitoring program of the Environmental Protection Agency,
the Institute of Public Health Belgrade in cooperation with the Secretar-
iat for Environmental Protection conducted monitoring of surface wa-
ters in 28 measurement sites on the smaller watercourses and the
Sava and Danube Rivers in the territory of Belgrade (IPHB, 2013). Re-
garding POP compounds, the concentrations of all substances in waters
and sediments were below the LOQs, except for PCBs in sediment of the
Veliki Lug River at the bridge on the road to Jagnjilo. At this location, the
PCB level was signiﬁcantly above MPC deﬁned in the relevant Serbian
regulation. This indicates there is a contaminated site in the wider
area acting as a source of PCBs in the water.
After the military conﬂict in 1999 and chemical accidents in
Kragujevac, Bor, Pancevo andNovi Sad, public attention has been partic-
ularly focused on pollution of the environment and possible conse-
quences on the health of the workers and local population. In
addition, there is still a relatively small quantity of data on contents of
relevant contaminants in environmental samples. Turk et al. (2007) an-
alyzed PCBs, HCHs, DDT and metabolites by active and passive air sam-
pling from three localities in Kragujevac. The concentration of PCB
congeners, combined α-, β- and γ-HCH, and DDT in Kragujevac were:
Table 1
Review of POP compounds and their effects on human health (ATSDR, 2018).
No POP compounds Type
of
POPs
Effects Critical effects Code for
carcinoma
Code for
other
effects
Annex A (elimination)
1 Aldrin Pa Neurological disorders, carcinogenic,
reproductive, endocrine
CNS excitation; transaminase; suspected human
carcinogen
K71-K73
2 Dieldrin P Neurological disorders, carcinogenic,
reproductive, endocrine
CNS excitation; transaminase; suspected human
carcinogen
G40-G47
3 Hexabromobiphenyl
(HBB)
ICb Skin changes (chlorine, hyperpigmentation);
neurological effects (muscle weakness and
spasms); carcinogenic
Thyroid gland, T4 decrease, suspected human
carcinogen (breast, digestive system and
lymphoma)
C50,
C15-C26,
C81-C84
E03
4 α-Hexachlorocyclohexane
(HCH)
P Neurological disorders, carcinogenic,
reproductive, endocrine
Hyperexcitability, epilepsy, convulsions, liver,
suspected human carcinogen
K71-K73
5 β-Hexachlorocyclohexane
(HCH)
P Neurological disorders, carcinogenic,
reproductive, endocrine
Hyperexcitability, epilepsy, convulsion and ataxia G11
6 Mirex P Hepatotoxicity, suspected human carcinogen K71-K73
7 Endosulfan and isomers P Neurological effects
8 Chlordane P GIT diseases, neurological, liver, carcinogenic Hepatotoxicity, suspected human carcinogen K71-K73
9 Endrin P CNS (Central Nervous System), etc. CNS convulsions G40-G47
10 Tetrabromodiphenyl ether
and pentabromodiphenyl
ether (penta-BDE)
IC Thyroid gland, neurological growth and
development, liver
Neurobehavioral effects, thyroid hormones
homeostasis, suspected human carcinogen
P05-P08, E03.2
11 hexabromodiphenyl ether
and heptabromodiphenyl
ether (octa-BDE)
IC Neurotoxicity, liver, thyroid, growth and
development
Hepatotoxicity (enzyme induction), suspected
human carcinogen
K71-K73
12 Pentachlorobenzene P
and
IC
Hepatotoxicity, nephrotoxicity K71-K73
13 Chlordecone P Renal effects, suspected human carcinogen N0-N19
14 Heptachlor P Neurological, liver, reproductive, growth and
development
Nervous and immune system development,
suspected human carcinogen
D80-D82
15 Hexachlorobenzene (HCB) P
and
IC
Hepatotoxicity, suspected human carcinogen
(thyroid, sarcomas)
C73, C46 K71-K73
16 Lindane P Immunological effects and toxicity to
reproduction, growth and development
P05-P08
17 PCBc IC Skin changes (chlorine, hyperpigmentation);
neurological effects (muscle weakness and
spasm); carcinogenic
Immunological effects, proneness to respiratory
system infections, suspected human carcinogen
D80-D82
18 Toxaphene P Fatty liver disease, tubular necrosis, suspected
human carcinogen
K73, N11
Annex B (restriction)
19 DDTd P Nervous system (fatigue, convulsions), fertility,
pregnancy maintenance, lactation duration
Hepatotoxicity, suspected human carcinogen K71-K73
20 PFOS, PFOSAe IC Fetus development, reproductive system of the
fetus, neuroendocrine, suspected human
carcinogen (bladder cancer)
P05-P08
Annex C (unintentionally produced, minimization, elimination)
21 PCDDf IC Chlorine, liver, thyroid, growth and development,
immune, reproductive, carcinogenic
Toxicity to growth and development (especially
of reproductive system), suspected human
carcinogen (sarcomas, lymphomas, respiratory
system, gastrointestinal system)
C46,
C81–C84,
C34, C26
P05-P08
22 PCDFg IC Chlorine, liver, thyroid, growth and development,
immune, reproductive, carcinogenic
liver (increased bilirubin, AST, ALT, TG),
suspected human carcinogen (skin and liver)
C43, C44,
C22
K71-K73
23 HBB, PBDEs, HBCD IC Liver, thyroid, growth and development, immune,
reproductive, carcinogenic
HBB: liver, immune, DNA; probably carcinogenic
to humans
C43, C44,
C22
K72, N0-N19,
E03, E08
24 PFOS IC Immune, liver, and endocrine systems,
carcinogenic
Immune, endocrine systems, possibly
carcinogenic to humans
C22 K72,E03, E08
a P – pesticides.
b IC – industrial chemicals.
c PCB - polychlorinated biphenyls.
d DDT – dichlorodiphenyltrichloroethane.
e PFOS - perﬂuorooctane sulfonate, PFOSA - perﬂuorooctane sulfonate.
f PCDD - polychlorinated dibenzodioxins.
g PCDF - polychlorinated dibenzofurans.
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respectively. The authors indicated that high levels of PCBs resulted
from the destruction of transformers during an accident in the 1999
war (Turk et al., 2007).
As a part of the ICPDR Joint Danube Survey 2, a high PFOS concentra-
tion of 20 ng/L has been identiﬁed at the conﬂuence of the Morava andDanube Rivers (ICPDR, 2015). Relatively high concentrations of
perﬂuorononanoic (PFNA), with an average value of 108 ng/L, were de-
tected in the Tisa River. In the same samples of the surface layers of the
Tisa River, perﬂuoroundecanoic acid (PFUnA), perﬂuorooctanoic acid
(PFOA) and PFOS were detected in maximum concentrations,
i.e., above 10 ng/L, 3 ng/L and 3 ng/L, respectively (Miloradov et al.,
Table 2
The cost to Serbia of medical treatment carcinoma that were potentially related to POP
compounds from 2011 to 2015.
Year 2011 2012 2013 2014 2015
Number of treated G1a patients
without repetition
118,720 114,678 109,644 126,337 125,908
Average cost (€) of G1 patient
treatment
1482 1360 1431 1455 1492
Total cost of G1 treatment in
millions of €
175.9 156.0 156.9 159.8 158.6
a G1 group consists of carcinogenic diseases.
Table 4
Estimated costs to Serbia of medical treatment for diseases caused by POP compounds, in
000 s of €.
Group Year 2011 2012 2013 2014 2015
G1a Total cost of G1 treatment 3518.9 3119.7 3137.9 3196.0 3172.5
G2b Total cost of G2 treatment 4745.7 4252.3 4659.8 5127.3 5201.4
TOTAL 8264.6 7372.0 7797.6 8323.2 8373.9
a G1 group consists of carcinogenic diseases.
b G2 group consists of non-carcinogenic diseases.
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trations in the Danube watershed sediment downstream from the
wastewater discharge location in the Pancevo industrial zone
(there is an oil reﬁnery and a petrochemical industrial complex
here). Downstream from HIP Petrochemicals in the Pancevo petro-
chemical complex, 130, 170 and 5700 ng/kg of dry substance PFOA,
PFHxA and PFOS, respectively, were detected, whereas downstream
from the NIS Oil Reﬁnery, also in Pancevo, 76, 66 and 420 ng/kg of
dry substance of PFOA, PFHxA and PFOS, respectively, were detected
(Beškoski et al., 2013).
In Serbia, 709 potentially contaminated and contaminated sites
were identiﬁed and recorded in the government land registry, of
which 557 sites are registered and 152 are presumed. Out of the 709
sites, 478 are still to be investigated and 103 are currently under inves-
tigation. Some sites (41) are in the process of rehabilitation, while reha-
bilitation and remediation (re-cultivation) are completed on 52 sites
where after-care measures are currently being applied.
The highest number of registered sources of local soil contamination
comes from municipal waste (43.5%), followed by the exploitation and
production of oil (31.7%), locations for passengers and commercial
transport (21.6%), industrial waste (7.2%) and from industrial and com-
mercial activities (10.2%) (SEPA, 2017a, 2017b).
This brief analysis of POPs in the environment in Serbia conﬁrms
the importance of adopting action plans for disposal and decontam-
ination of POPs, thus preventing the further release of POPs into the
compartments of the environment and food chain. One of the key
methodological questions in the process of assessing costs of suitable
action plans is how to, above all, as precisely as possible, determine
these costs, and then to separate them from other costs of environ-
mental protection. This is difﬁcult because, very often, inﬂuences of
POPs are manifested together with inﬂuences of other substances,
and therefore, measures and instruments for their mitigation are ap-
plied simultaneously. For this reason, special attention was devoted
to the separation of costs that are directly and exclusively related
to POP compounds.
According to methodology given in UNIP (UNIP, 2015), the total
cost of disposal of and decontamination from POPs chemicals in
Serbia is calculated at € 24,582,000 (scenario for 5-year phase out)Table 3
The cost to Serbia of medical treatment for patients with diagnosed G2 (non-carcinoma)
diseases.
Year 2011 2012 2013 2014 2015
Number of treated G2a patients
without repetition
234,943 237,931 256,399 353,066 347,482
Average cost (€) of G2 patient
treatment
1010 894 909 835 886
Total cost of G2 treatment in
millions of €
237.3 212.6 233.0 256.4 260.1
a G2 group consists of non-carcinogenic diseases.and includes: properly disposed an existing quantities of POPs pesti-
cides waste, decontamination of PCB containing equipment with the
volume larger than 5 dm3 and with PCB concentration above
50 ppm, improving system of monitoring and reporting and releases
of unintentionally produced POPs chemicals into environment, es-
tablishing system for safe storage and treatment of chemicals,
semi-ﬁnished products and products containing PBDEs, HBB and
HBCD chemicals and waste containing these chemicals and reducing
environmental pollution through remediation of identiﬁed POPs pol-
luted areas (Fig. 1).
Finally, it is important to remember that all of the mentioned ﬁnan-
cial projections are rough estimations, being only a preliminary assess-
ment that should be additionally speciﬁed (UNIP, 2015).
3.3. Socio-economic impact of POPs in Serbia
The indicators of the impact POP chemicals have on economic activ-
ities are shown in this study as a relative share of gross domestic prod-
uct (GDP). In that sense, costs of medical treatments as a possible
consequence of pollution are expressed as percentages of GDP which
has been spent or lost (Table 5) (FREN, 2017).
It is important to note that the adverse human health effects are
manifested further in the economic sphere of society mainly through:
loss of family income due to death of a family member; reduction of in-
comedue to reducedworking ability caused bydisease and/or increased
medical costs, and; increased cost of public health. Besides that, adverse
effects on the environment include loss of biodiversity, decreased agri-
cultural production levels and decreased food production (an important
sector in the Serbian economy).
Using calculated costs in previous sector/chapters, it is possible to
calculate the beneﬁt:cost ratio (BCR) of phasing out and mitigating
POP compounds in the environment over a 5-year period:
BCR ¼ value of benefits=value of costs ¼ 2:77
value of beneﬁts: cost of G1 (G1 group consists of carcinogenic diseases)
and G2 (G2 group consists of non-carcinogenic diseases) medical treat-
ment for ﬁve years (€ 68,019,152) value of costs: cost of disposal and de-
contamination scenario for 5-year phase out (€ 24,582,000).
Since it is likely the Serbian populationwill become further educated
about the importance of a reduce, reuse and recycle ethos and the effec-
tiveness of a circular economy, as experts from this ﬁeld have proved
(Robertson et al., 2018), the potential BCR should be assumed as being
greater than this calculated value.
4. Conclusions
In conclusion, we have emphasized monetization of cost of
diseases possibly caused by a speciﬁc group of hazardous chemicals,
POPs, as inventoried in Serbia from 2011 to 2015. According to this
BCR, every € 1 of cost will return € 2.77 of beneﬁt after a 5-year
period. We stress this is without the uncertainty of environmental
beneﬁts being monetized due to data gaps and the complexity of
environmental services. The process of socio-economic analysis of
Fig. 1. Cost projections for disposal of and decontamination environment from POPs chemicals in Serbia.
492 J. Milic et al. / Science of the Total Environment 688 (2019) 486–493hazardous chemicals impacts includes identifying anthropogenic ac-
tivities which include dangerous chemicals; analyzing their adverse
effects on the environment, and; assessing their impacts. Methods
and indicators for measuring these impacts, and when possible mon-
etizing them, contain some uncertainties. Therefore, these data
should be used as an illustration of this comprehensive issue, and
to underpin further, more precise calculations for national, health
and environmental beneﬁts.
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